SCHEMBL6974927

SCHEMBL6974927

c1ccc2c(c1)CCC2CCN1CCN(c2ccc3c(c2)OCO3)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.49
HTR1A P08908 3/20 0.49
ADRA2A P08913 2/20 0.49
ADRA2C P18825 2/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
DRD3 P35462 2/20 0.49
SIGMAR1 Q99720 1/20 0.49
DRD4 P21917 3/20 0.46
HTR2A P28223 2/20 0.46
ADRA2B P18089 1/20 0.46
DRD1 P21728 1/20 0.46
HTR2B P41595 1/20 0.46
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6972679 0.92 MAPT (0.45) DRD2HTR1AADRA2AADRA2CADRA1D
Fumaric Acid SCHEMBL6972673 0.92 MAPT (0.45) DRD2HTR1AADRA2AADRA2CADRA1D
SCHEMBL6960133 0.90 DRD2 (0.58) DRD2HTR1AADRA2AADRA2CADRA1D
SCHEMBL9014693 0.87 SIGMAR1 (0.55) DRD2HTR1AADRA2AADRA2CADRA1D
Hydrochloric Acid SCHEMBL10407883 0.84 KCNH2 (0.50) DRD2HTR1AADRA2AADRA2CADRA1D
SCHEMBL7402139 0.83 DRD2 (0.69) DRD2HTR1AADRA2AADRA2CADRA1D
SCHEMBL7812153 0.82 HTR1A (0.63) DRD2HTR1AADRA2AADRA2CADRA1D
Hydrochloric Acid SCHEMBL7408947 0.82 DRD2 (0.67) DRD2HTR1AADRA2AADRA2CADRA1D
SCHEMBL7405539 0.79 ALDH1A1 (0.53) DRD2HTR1AADRA2AADRA2CADRA1D
Hydrochloric Acid SCHEMBL10408656 0.79 HTR1A (0.53) DRD2HTR1AADRA2AADRA2CADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946538-B1 INDANE OR DIHYDROINDOLE DERIVATIVES LUNDBECK & CO AS H (DK) 2003-08-06 EP claimed
US-20010051625-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-12-13 US claimed
EP-0946538-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP claimed
WO-1998028290-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1998-07-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051625-A1 Indane or dihydroindole derivatives DRD2, SLC6A3, DRD1 DRD2 1/4885HTR1A 16/4885ADRA2A 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.